COVID 19. Corona virus infection, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients in the target group will receive the target group drug after treatment with routine medications. To prepare the target drug, 1000 g of Amla fruit is soake
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age =18 years Laboratory polymerase chain reaction (PCR) confirmed infection with COVID19 Lung involvement confirmed with chest imaging Hospitalized with: Fever or Respiratory rate >24/min Or Cough Less than 8 days since illness onset Willingness of study participant to accept randomization to any assigned treatment arm Acceptance of non-participation in another study before the 28th day of the study
Exclusion criteria
Exclusion criteria: Receipt of any experimental treatment for COVID 19 within the 30 days prior to the time of the screening evaluation Severe liver disease Known allergic reaction to drugs Severe renal disease Pregnant or breastfeeding women Transfer to another hospital within the next 72 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Viral diagnostic test. Timepoint: The first day of the study and the end of the study. Method of measurement: Polymerase chain reaction. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: Daily. Method of measurement: Thermometer.;Chill. Timepoint: Daily. Method of measurement: Patients interview and patient file.;Respiratory Rate. Timepoint: Daily. Method of measurement: Patients interview and patient file.;Dyspnea. Timepoint: Daily. Method of measurement: Patients interview and patient file.;Cough. Timepoint: Daily. Method of measurement: Patients interview and patient file.;Body Pain. Timepoint: Daily. Method of measurement: Patients interview and patient file.;Weakness. Timepoint: Daily. Method of measurement: Patients interview and patient file.;Lymphocyte blood count. Timepoint: The first day of the study and the end of the. Method of measurement: Cell counter.;C_reactive protein. Timepoint: The first day of the study and the end of the. Method of measurement: Agglutination Kit.;Erythrocyte sedimentation Rate. Timepoint: The first day of the study and the end of the study. Method of measurement: Wester Green.;Neutrophyle blood count. Timepoint: The first day of the study and the end of the study. Method of measurement: Cell counter.;Platelet. Timepoint: The first day of the study and the end of the study. Method of measurement: Cell counter.;Chest CT Scan. Timepoint: The first day of the study and the end of the study. Method of measurement: CT scan set. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehran Varnaseri Ghandali
Ahvaz University of Medical Sciences
Outcome results
None listed